
1001 - 5000 Mitarbeiter
Gegründet 2002
🧬 Biotechnologie
💊 Pharmazie
🏥 Gesundheitswesen
💰 €661.250.000 Post-IPO Debt im 2025-09
Biotechnology • Pharmaceuticals • Healthcare
Alnylam Pharmaceuticals ist ein biopharmazeutisches Unternehmen, das RNA-Interference-(RNAi)-Therapeutika entwickelt, um krankheitsverursachende Gene gezielt abzuschalten. Das Unternehmen entwickelt RNAi-basierte Medikamente für seltene und häufige Erkrankungen. Die Pipeline, die zugelassenen Produkte und die Herstellungskapazitäten konzentrieren sich auf die Bereitstellung wegweisender Therapien, beispielsweise gegen Amyloidose, akute hepatische Porphyrie und primäre Hyperoxalurie. Alnylam legt großen Wert auf wissenschaftliche Innovation, eine patientenzentrierte Entwicklung und unternehmerische Verantwortung.
🕒 vor 5 Tagen
🌽 Illinois, Missouri – Remote
💵 $204.000 - $276.000 / Jahr
⏰ Vollzeit
🔴 Experte
👔 Direktor
👻 Geisterscore 0%
🗣️🇺🇸🇬🇧 Englisch erforderlich
Woher diese Stelle stammt
Veröffentlicht auf der Karriereseite von Alnylam Pharmaceuticals, nicht über eine Jobbörse
Von Remote Rocketship zum ersten Mal gesehen vor 5 Tagen
Noch offen auf der Website von Alnylam Pharmaceuticals. Geprüft vor 28 Minuten.

1001 - 5000 Mitarbeiter
Gegründet 2002
🧬 Biotechnologie
💊 Pharmazie
🏥 Gesundheitswesen
💰 €661.250.000 Post-IPO Debt im 2025-09
Biotechnology • Pharmaceuticals • Healthcare
Alnylam Pharmaceuticals ist ein biopharmazeutisches Unternehmen, das RNA-Interference-(RNAi)-Therapeutika entwickelt, um krankheitsverursachende Gene gezielt abzuschalten. Das Unternehmen entwickelt RNAi-basierte Medikamente für seltene und häufige Erkrankungen. Die Pipeline, die zugelassenen Produkte und die Herstellungskapazitäten konzentrieren sich auf die Bereitstellung wegweisender Therapien, beispielsweise gegen Amyloidose, akute hepatische Porphyrie und primäre Hyperoxalurie. Alnylam legt großen Wert auf wissenschaftliche Innovation, eine patientenzentrierte Entwicklung und unternehmerische Verantwortung.
• Lead strategic engagement and contracting with target key accounts to drive growth, revenue, joint value creation, and access to Alnylam products • Develop and execute comprehensive account strategies for target accounts • Analyze information from multiple sources to identify and prioritize business opportunities • Co-develop strategies, program objectives, and KPIs with the Alnylam Leadership Team • Prioritize solutions, programs, and pull-through tactics for sustainable growth and mutual value creation • Anticipate market and customer developments and adjust account strategy • Partner with healthcare systems and organized customers to foster innovation in care through adoption of Alnylam products • Engage senior stakeholders to influence policies, decisions, and perceptions • Facilitate introductions of new products and indications and support strategic account budget allocation • Maximize access to Alnylam products and identify programs that enhance care systems and clinical decision-making • Provide scientific, clinical, and technological insights, education, and information • Build and maintain relationships with senior stakeholders in target accounts • Establish treatment pathways and protocols to support patient identification and care delivery • Direct other field teams in identifying and prioritizing stakeholders • Negotiate, review, and agree contracts with strategic account stakeholders • Collaborate with functional and business leaders to incorporate customer insights into strategic planning • Support contracting and initiatives with national organized customers • Measure, report, and communicate value delivered • Share insights from customer engagement
• Bachelor’s degree, with emphasis in Accounting, Marketing, Business Administration or equivalent work experience in business management • Minimum 7 years of experience in B2B selling in a life sciences environment • Previous account management experience with health systems and/or hospitals/IDNs • Ability to understand and communicate complex scientific concepts to a range of stakeholders • Executive presence and communication skills to engage with a C-Suite audience • Expertise in dynamic market access value models, including value-based propositions, budget impact, and cost-effectiveness models • Strong written and oral communication skills • Ability to synthesize data and translate it into clear commercial strategies and plans • Ability to mobilize cross-functional teams and lead without direct authority in a highly matrixed environment • Understanding of the IDN environment, including coverage and reimbursement, pricing and contracting, formulary management, and health technology assessment • Strong analytical and critical-thinking skills • Ability to synthesize qualitative and quantitative multi-source information • Knowledge of value-based healthcare and outcome-based models • Ability to interact and negotiate with C-suite customers • Highly proficient in Microsoft Excel, Word, and PowerPoint • Master’s degree/MBA preferred • Active membership of relevant pharmaceutical associations beneficial
• Annual short-term incentive award (e.g., bonus or sales incentive) • Annual long-term incentive award (e.g., equity) • Medical coverage • Dental coverage • Vision coverage • Life insurance • Disability insurance • Lifestyle reimbursement program • Flexible spending accounts • Health savings accounts • 401(k) with a generous company match • Paid time off • Wellness days • Holidays • Two company-wide recharge breaks • Family resources and leave
Jetzt BewerbenVerbessern Sie Ihre Chancen auf ein Vorstellungsgespräch, indem Sie Ihre Lebenslauf-Bewertung vor der Bewerbung überprüfen.
🕒 vor 5 Tagen
Director of Digital Analytics turning retailer and platform data into measurement and growth decisions. Helping PLTFRM’s consumer-brand clients improve sales, media, content, and assortment performance.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 5 Tagen
HEOR director advancing global oncology evidence strategies at Corcept, a biopharmaceutical company developing cortisol-modulating treatments. Leading health economics, real-world evidence, modeling, HTA, and payer-engagement initiatives.
🇺🇸 Vereinigte Staaten – Remote
💵 $192.000 - $250.000 / Jahr
💰 €525.300 Post-IPO Equity im 2012-04
⏰ Vollzeit
🔴 Experte
👔 Direktor
🦅 H1B-Visum-Sponsor
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 5 Tagen
Compensation Director leading pay strategy, salary structures, incentives, and compliance. Advising leaders and managing compensation programs at CRC Group, a specialty insurance distributor.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 5 Tagen
Atlassian Delivery Director overseeing enterprise platform delivery, client relationships, and engagement financials. Leading Atlassian practice growth and globally distributed consulting teams at AI-first Cprime.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 5 Tagen
Director leading CDMO strategy, supply, and compliance for Praxis, a clinical-stage biopharmaceutical company developing CNS therapies. Managing outsourced API and drug product manufacturing.
🇺🇸 Vereinigte Staaten – Remote
💵 $210.000 - $235.000 / Jahr
⏰ Vollzeit
🔴 Experte
👔 Direktor
🦅 H1B-Visum-Sponsor
🗣️🇺🇸🇬🇧 Englisch erforderlich